RNA Splicing Events in Circulation Distinguish Individuals With and Without New-onset Type 1 Diabetes

被引:1
|
作者
Webb-Robertson, Bobbie-Jo M. [1 ]
Wu, Wenting [2 ]
Flores, Javier E. [1 ]
Bramer, Lisa M. [1 ]
Syed, Farooq [2 ]
Tersey, Sarah A. [3 ,4 ]
May, Sarah C. [3 ,4 ]
Sims, Emily K. [2 ]
Evans-Molina, Carmella [2 ,5 ]
Mirmira, Raghavendra G. [3 ,4 ]
机构
[1] Pacific Northwest Natl Lab, Biol Sci Div, Richland, WA 99354 USA
[2] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA
[3] Univ Chicago, Diabet Res & Training Ctr, Chicago, IL 60637 USA
[4] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[5] Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA
基金
美国国家卫生研究院;
关键词
type; 1; diabetes; machine learning; alternative RNA splicing; biomarkers; RECEPTOR;
D O I
10.1210/clinem/dgae622
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Alterations in RNA splicing may influence protein isoform diversity that contributes to or reflects the pathophysiology of certain diseases. Whereas specific RNA splicing events in pancreatic islets have been investigated in models of inflammation in vitro, how RNA splicing in the circulation correlates with or is reflective of type 1 diabetes (T1D) disease pathophysiology in humans remains unexplored.Objective To use machine learning to investigate if alternative RNA splicing events differ between individuals with and without new-onset T1D and to determine if these splicing events provide insight into T1D pathophysiology.Methods RNA deep sequencing was performed on whole blood samples from 2 independent cohorts: a training cohort consisting of 12 individuals with new-onset T1D and 12 age- and sex-matched nondiabetic controls and a validation cohort of the same size and demographics. Machine learning analysis was used to identify specific isoforms that could distinguish individuals with T1D from controls.Results Distinct patterns of RNA splicing differentiated participants with T1D from unaffected controls. Notably, certain splicing events, particularly involving retained introns, showed significant association with T1D. Machine learning analysis using these splicing events as features from the training cohort demonstrated high accuracy in distinguishing between T1D subjects and controls in the validation cohort. Gene Ontology pathway enrichment analysis of the retained intron category showed evidence for a systemic viral response in T1D subjects.Conclusion Alternative RNA splicing events in whole blood are significantly enriched in individuals with new-onset T1D and can effectively distinguish these individuals from unaffected controls. Our findings also suggest that RNA splicing profiles offer the potential to provide insights into disease pathogenesis.
引用
收藏
页码:1148 / 1157
页数:10
相关论文
共 50 条
  • [31] Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension
    Hu, Yuhang
    Zhang, Jingjing
    Liu, Wei
    Su, Xin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (04) : 1079 - 1085
  • [32] Healthcare Costs for Initial Management of Children with New-Onset Type 1 Diabetes Mellitus in Central and Northern Alberta
    Foulds, Jessica L.
    Vanderloo, Saskia E.
    Marks, Seth D.
    Johnson, Jeffrey A.
    CANADIAN JOURNAL OF DIABETES, 2012, 36 (03) : 128 - 132
  • [33] Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes
    Oldfield, Lucy
    Evans, Anthony
    Rao, Rohith Gopala
    Jenkinson, Claire
    Purewal, Tejpal
    Psarelli, Eftychia E.
    Menon, Usha
    Timms, John F.
    Pereira, Stephen P.
    Ghaneh, Paula
    Greenhalf, William
    Halloran, Christopher
    Costello, Eithne
    EBIOMEDICINE, 2022, 75
  • [34] Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults
    Scholin, A.
    Nystrom, L.
    Arnqvist, H.
    Bolinder, J.
    Bjork, E.
    Berne, C.
    Karlsson, F. A.
    DIABETIC MEDICINE, 2011, 28 (02) : 156 - 161
  • [35] Comparison of the dietary intakes of individuals with and without type 1 diabetes in China
    Jaacks, Lindsay M.
    Du, Shufa
    Mendez, Michelle A.
    Crandell, Jamie
    Liu, Wei
    Ji, Linong
    Rosamond, Wayne
    Popkin, Barry M.
    Mayer-Davis, Elizabeth J.
    ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2015, 24 (04) : 639 - 649
  • [36] New-onset type 1 diabetes and Graves' disease after antiretroviral therapy in a patient with human immunodeficiency virus infection
    Taguchi, Maho
    Ihana-Sugiyama, Noriko
    Shiojiri, Daisuke
    Izumi, Kazuo
    Kobayashi, Michi
    Kodani, Noriko
    Bouchi, Ryotaro
    Ohsugi, Mitsuru
    Tanabe, Akiyo
    Ueki, Kohjiro
    Kajio, Hiroshi
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (03) : 489 - 493
  • [37] New onset diabetes, type 1 diabetes and COVID-19
    Boddu, Sirisha Kusuma
    Aurangabadkar, Geeta
    Kuchay, Mohammad Shafi
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (06) : 2211 - 2217
  • [38] A patient diagnosed with new-onset type 1 diabetes and Addison's disease at initial presentation
    Towslee, Emma
    Macdonald, Adrienne
    Shoar, Zohreh
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2024, 2024 (02)
  • [39] Delayed referral is common even when new-onset diabetes is suspected in children. A Swedish prospective observational study of diabetic ketoacidosis at onset of Type 1 diabetes
    Wersall, Johan H.
    Adolfsson, Peter
    Forsander, Gun
    Ricksten, Sven-Erik
    Hanas, Ragnar
    PEDIATRIC DIABETES, 2021, 22 (06) : 900 - 908
  • [40] Stressful life events, parental psychosocial factors, and glycemic management in school-aged children during the 1 year follow-up of new-onset type 1 diabetes
    Stanek, Kelly R.
    Noser, Amy E.
    Patton, Susana R.
    Clements, Mark A.
    Youngkin, Erin M.
    Majidi, Shideh
    PEDIATRIC DIABETES, 2020, 21 (04) : 673 - 680